Sriamornsak P[auth] - Search Results

Year	Number of Results
1998	1
1999	3
2002	1
2003	2
2004	3
2005	2
2006	6
2007	12
2008	9
2009	1
2010	3
2011	4
2012	5
2013	6
2014	6
2015	5
2016	6
2017	12
2018	7
2019	2
2020	1
2021	3
2022	7
2023	7
2024	2

1

Chitosan Nanoparticles in Atherosclerosis-Development to Preclinical Testing.

Sriamornsak P, Dass CR. Sriamornsak P, et al. Pharmaceutics. 2022 Apr 25;14(5):935. doi: 10.3390/pharmaceutics14050935. Pharmaceutics. 2022. PMID: 35631521 Free PMC article. Review.

2

Special issue: Pharmaceutical innovation.

Sriamornsak P, Shuwisitkul D. Sriamornsak P, et al. Asian J Pharm Sci. 2018 Sep;13(5):395-397. doi: 10.1016/j.ajps.2018.07.001. Epub 2018 Jul 31. Asian J Pharm Sci. 2018. PMID: 32104413 Free PMC article.

3

Himalayan flora: targeting various molecular pathways in lung cancer.

James A, Akash K, Sharma A, Bhattacharyya S, Sriamornsak P, Nagraik R, Kumar D. James A, et al. Among authors: sriamornsak p. Med Oncol. 2023 Oct 3;40(11):314. doi: 10.1007/s12032-023-02171-x. Med Oncol. 2023. PMID: 37787816 Review.

4

Recent advances in dosage form design for the elderly: a review.

Salave S, Patel P, Desai N, Rana D, Benival D, Khunt D, Thanawuth K, Prajapati BG, Sriamornsak P. Salave S, et al. Among authors: sriamornsak p. Expert Opin Drug Deliv. 2023 Jul-Dec;20(11):1553-1571. doi: 10.1080/17425247.2023.2286368. Epub 2023 Dec 20. Expert Opin Drug Deliv. 2023. PMID: 37978899 Review.

5

Practical Application of 3D Printing for Pharmaceuticals in Hospitals and Pharmacies.

Huanbutta K, Burapapadh K, Sriamornsak P, Sangnim T. Huanbutta K, et al. Among authors: sriamornsak p. Pharmaceutics. 2023 Jul 4;15(7):1877. doi: 10.3390/pharmaceutics15071877. Pharmaceutics. 2023. PMID: 37514063 Free PMC article. Review.

6

Targeted therapy for cancer using pH-responsive nanocarrier systems.

Manchun S, Dass CR, Sriamornsak P. Manchun S, et al. Among authors: sriamornsak p. Life Sci. 2012 Mar 10;90(11-12):381-7. doi: 10.1016/j.lfs.2012.01.008. Epub 2012 Feb 1. Life Sci. 2012. PMID: 22326503 Review.

7

Application of pectin in oral drug delivery.

Sriamornsak P. Sriamornsak P. Expert Opin Drug Deliv. 2011 Aug;8(8):1009-23. doi: 10.1517/17425247.2011.584867. Epub 2011 May 13. Expert Opin Drug Deliv. 2011. PMID: 21564000 Review.

8

Editorial: Biodegradable Drug Delivery Systems for Cancer Therapy.

Wong TW, Sriamornsak P, Dass CR. Wong TW, et al. Among authors: sriamornsak p. Curr Drug Deliv. 2017;14(8):1052. doi: 10.2174/156720181408171213150655. Curr Drug Deliv. 2017. PMID: 29290178 No abstract available.

9

Dissolvable shower gel tablets with enhanced skin benefits.

Huanbutta K, Sripirom P, Phetthong P, Thalerngkiatsiri P, Kabthong N, Sangnim T, Sriamornsak P. Huanbutta K, et al. Among authors: sriamornsak p. Int J Cosmet Sci. 2023 Dec;45(6):739-748. doi: 10.1111/ics.12882. Epub 2023 Aug 6. Int J Cosmet Sci. 2023. PMID: 37402220

10

Pectin hydrogels for controlled drug release: Recent developments and future prospects.

Kapoor DU, Garg R, Gaur M, Pareek A, Prajapati BG, Castro GR, Suttiruengwong S, Sriamornsak P. Kapoor DU, et al. Among authors: sriamornsak p. Saudi Pharm J. 2024 Apr;32(4):102002. doi: 10.1016/j.jsps.2024.102002. Epub 2024 Feb 24. Saudi Pharm J. 2024. PMID: 38439951 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

91 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Results by year